Get it on Google Play
New! Download Unionpedia on your Android™ device!
Faster access than browser!


Index Ozarelix

Ozarelix (developmental code names D-63153, SPI-153) is a peptide gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by AEterna Zentaris Inc. [1]

12 relations: Acetate, Alzheimer's disease, Antigonadotropin, Benign prostatic hyperplasia, Clinical trial, Endometriosis, GnRH modulator, Gonadotropin-releasing hormone antagonist, Injection (medicine), Peptide, Pharmaceutical formulation, Prostate cancer.


An acetate is a salt formed by the combination of acetic acid with an alkaline, earthy, metallic or nonmetallic and other base.

New!!: Ozarelix and Acetate · See more »

Alzheimer's disease

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time.

New!!: Ozarelix and Alzheimer's disease · See more »


An antigonadotropin is a drug which suppresses the activity and/or downstream effects of one or both of the gonadotropins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).

New!!: Ozarelix and Antigonadotropin · See more »

Benign prostatic hyperplasia

Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate.

New!!: Ozarelix and Benign prostatic hyperplasia · See more »

Clinical trial

Clinical trials are experiments or observations done in clinical research.

New!!: Ozarelix and Clinical trial · See more »


Endometriosis is a condition in which the endometrium, the layer of tissue that normally covers the inside of the uterus, grows outside of it.

New!!: Ozarelix and Endometriosis · See more »

GnRH modulator

A GnRH modulator, or GnRH receptor modulator, is a type of drug which modulates the GnRH receptor, the biological target of gonadotropin-releasing hormone (GnRH).

New!!: Ozarelix and GnRH modulator · See more »

Gonadotropin-releasing hormone antagonist

Gonadotropin-releasing hormone antagonists (GnRH antagonists) are a class of medications that antagonize the gonadotropin-releasing hormone receptor (GnRH receptor) and thus the action of gonadotropin-releasing hormone (GnRH).

New!!: Ozarelix and Gonadotropin-releasing hormone antagonist · See more »

Injection (medicine)

Injection (often referred to as a "shot" in US English, or a "jab" in UK English) is the act of putting a liquid, especially a drug, into a person's body using a needle (usually a hypodermic needle) and a syringe.

New!!: Ozarelix and Injection (medicine) · See more »


Peptides (from Gr.: πεπτός, peptós "digested"; derived from πέσσειν, péssein "to digest") are short chains of amino acid monomers linked by peptide (amide) bonds.

New!!: Ozarelix and Peptide · See more »

Pharmaceutical formulation

Pharmaceutical formulation, in pharmaceutics, is the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product.

New!!: Ozarelix and Pharmaceutical formulation · See more »

Prostate cancer

Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.

New!!: Ozarelix and Prostate cancer · See more »

Redirects here:

D 63,153, D 63153, D-63,153, D-63153, D63153, Ozarelix acetate, SPI 153, SPI-153, SPI153.


[1] https://en.wikipedia.org/wiki/Ozarelix

Hey! We are on Facebook now! »